Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Caitlin A. McIntyre

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7206-2433; OpenAlex author ID A5034991877. Sources: OpenAlex.

Their work

Papers
17 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
91
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers · 2026: 2 papers

Papers 17

  1. Genomic evolution of pancreatic cancer at single-cell resolution. Co-author DOI 10.1038/s41588-025-02468-9↗
  2. POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer Co-author DOI 10.64898/2026.03.15.711961↗
  3. Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.70088↗
  4. The Evolutionary Forest of Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-1541↗
  5. Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer. Co-author DOI 10.1016/j.ccell.2024.08.002↗
  6. Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. Co-author DOI 10.1200/jco.23.01311↗
  7. Unveiling the Promise: Navigating Clinical Trials 1978-2024 for PDAC. Co-author DOI 10.3390/cancers16213564↗
  8. Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer. Co-author DOI 10.1038/s41467-023-36344-z↗
  9. Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.26735↗
  10. Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adeno… Co-author DOI 10.1177/0003134821989050↗
  11. Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? Co-author DOI 10.1245/s10434-022-11579-0↗
  12. Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery. First author DOI 10.1007/s00261-020-02726-w↗
  13. Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model. Co-author DOI 10.1200/cci.21.00001↗
  14. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cncr.33038↗
  15. Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41379-020-0549-5↗
  16. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-019-02112-1↗
  17. Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma. Co-author DOI 10.1053/j.seminoncol.2014.12.003↗

Closest collaborators

The 25 strongest of 91 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eileen Mary O'Reilly · 9 shared papers, 2020–2026 · strength 1.34
  2. Vinod P. Balachandran · 8 shared papers, 2019–2026 · strength 1.04
  3. Christine A. Iacobuzio–Donahue · 7 shared papers, 2019–2026 · strength 1.04
  4. William R. Jarnagin · 8 shared papers, 2019–2025 · strength 1.00
  5. Michael Ian D'Angelica · 8 shared papers, 2019–2025 · strength 0.95
  6. Alice Chia-Chi Wei · 6 shared papers, 2021–2026 · strength 0.94
  7. Akimasa Hayashi · 5 shared papers, 2020–2026 · strength 0.88
  8. Wungki Park · 5 shared papers, 2020–2026 · strength 0.86
  9. Jeffrey A. Drebin · 7 shared papers, 2019–2025 · strength 0.86
  10. Haochen Zhang · 4 shared papers, 2023–2026 · strength 0.78
  11. Kevin C. Soares · 4 shared papers, 2022–2026 · strength 0.65
  12. T. Peter Kingham · 6 shared papers, 2019–2022 · strength 0.65
  13. Jungeui Hong · 3 shared papers, 2023–2026 · strength 0.59
  14. Marinela Capanu · 4 shared papers, 2020–2026 · strength 0.57
  15. Anna M. Varghese · 4 shared papers, 2020–2026 · strength 0.50
  16. Benjamin J. Raphael · 2 shared papers, 2025–2026 · strength 0.43
  17. Marc Hilmi · 2 shared papers, 2026 · strength 0.42
  18. Peter J. Allen · 4 shared papers, 2019–2022 · strength 0.41
  19. Kenneth H. Yu · 3 shared papers, 2020–2026 · strength 0.40
  20. Olca Baştürk · 3 shared papers, 2019–2026 · strength 0.36
  21. Alvin P. Makohon-Moore · 2 shared papers, 2023–2025 · strength 0.36
  22. Katelyn Mullen · 2 shared papers, 2023–2025 · strength 0.36
  23. Richard Kinh Gian · 3 shared papers, 2019–2022 · strength 0.30
  24. Amber L. Simpson · 3 shared papers, 2019–2022 · strength 0.30
  25. Marc A. Attiyeh · 2 shared papers, 2019–2025 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.